Skip to content
Menu
Close
About us
Overview
Philosophy
World’s best cancer clinic
Oncologists
Team
Your way to us
Your analysis
Integrative medicine
News
Therapies
Overview
Cancer Therapies
Immunotherapies
Stage 4 Cancer Therapies
Indications
Overview
Brain Tumors
Breast Cancer
CUP-Syndrome
Gastrointestinal Tumors
Haematological Disorders
Head and Neck Tumors
Kidney Cancer
Liver Cancer
Lung Cancer
Neuroendocrine Tumors
Other Diagnosis
Ovarian Cancer
Pancreatic Cancer
Sarcomas
Skin Cancer
Urogenital Tumors
Experiences
Overview
Breast Cancer
Ovarian Cancer
Gastronintestinal Tumors
Skin Cancer
Brain Tumors
Head and Neck Tumors
Liver Cancer
Lung Cancer
Lymphoma
Kidney Cancer
Sarcomas
Cervical Carcinoma
FAQ
Facebook
X
YouTube
Instagram
LinkedIn
en
de
Contact
Contact
en
de
Back
News - 02/22/2019
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma.
